Mostrar el registro sencillo del ítem

dc.contributor.author
Rodríguez, Carlos Hernán  
dc.contributor.author
De Ambrosio, Alejandra  
dc.contributor.author
Bajuk, Milena  
dc.contributor.author
Spinozzi, Mariela  
dc.contributor.author
Nastro, Marcela  
dc.contributor.author
Bombicino, Karina  
dc.contributor.author
Radice, Marcela Alejandra  
dc.contributor.author
Gutkind, Gabriel Osvaldo  
dc.contributor.author
Vay, Carlos  
dc.contributor.author
Famiglietti, Ángela  
dc.date.available
2017-05-15T17:29:19Z  
dc.date.issued
2010-03  
dc.identifier.citation
Rodríguez, Carlos Hernán; De Ambrosio, Alejandra; Bajuk, Milena; Spinozzi, Mariela; Nastro, Marcela; et al.; In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones; Open Learning on Enteric Pathogens; Journal of Infection in Developing Countries; 4; 3; 3-2010; 164-167  
dc.identifier.issn
2036-6590  
dc.identifier.uri
http://hdl.handle.net/11336/16481  
dc.description.abstract
BACKGROUND: Multidrug-resistant strains of Acinetobacter baumannii have been reported increasingly around the world. The administration of an association of antibiotics has been proposed to create an active combination and to prevent the emergence of resistance. METHODOLOGY: The activity of colistin, rifampicin, gentamicin, imipenem and their associations was evaluated by means of killing curves in fourteen isolates belonging to three endemic PFGE types, in a university hospital of Buenos Aires city. The 14 isolates were selected on the basis of different mechanisms responsible for resistance to carbapenems and different susceptibility to colistin. RESULTS: The mechanism responsible for the resistance to imipenem was the production of OXA-23 and OXA-58 carbapenemases. Heteroresistance to colistin was observed in six isolates. The associations colistin-rifampicin and colistin-imipenem were synergistic in heteroresistant isolates and prevented the development of colistin-resistant mutants. The association imipenem-gentamicin was bactericidal in gentamicin susceptible isolates, whereas the association imipenem-rifampicin was always indifferent. CONCLUSION: The antimicrobial activity and the presence of synergy are related to the antimicrobials' susceptibilities irrespective of the PFGE type or the OXA-carbapenemase produced.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Open Learning on Enteric Pathogens  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Acinetobacter Baumannii  
dc.subject
Antimicrobials Activity  
dc.subject
Antimicrobial Resistance  
dc.subject
Time-Kill Assay  
dc.subject
Colistin-Heteroresistance  
dc.subject
Rifampicin  
dc.subject
Imipenem  
dc.subject.classification
Enfermedades Infecciosas  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
In vitro antimicrobials activity against endemic Acinetobacter baumannii multiresistant clones  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2017-05-10T19:58:55Z  
dc.identifier.eissn
1972-2680  
dc.journal.volume
4  
dc.journal.number
3  
dc.journal.pagination
164-167  
dc.journal.pais
Italia  
dc.journal.ciudad
Sácer  
dc.description.fil
Fil: Rodríguez, Carlos Hernán. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: De Ambrosio, Alejandra. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina  
dc.description.fil
Fil: Bajuk, Milena. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina  
dc.description.fil
Fil: Spinozzi, Mariela. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica; Argentina  
dc.description.fil
Fil: Nastro, Marcela. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Bombicino, Karina. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Radice, Marcela Alejandra. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Gutkind, Gabriel Osvaldo. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Microbiología, Inmunología y Biotecnología; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Vay, Carlos. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.description.fil
Fil: Famiglietti, Ángela. Universidad de Buenos Aires. Facultad de Farmacia y Bioquímica. Departamento de Bioquímica Clínica; Argentina. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina  
dc.journal.title
Journal of Infection in Developing Countries  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://jidc.org/index.php/journal/article/view/20351457  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3855/jidc.604